Novavax Inc NVAX Hisse Senedi Tahmini
Novavax Inc için AI destekli fiyat tahmini ve analiz · Güncellenmiş Nis 02, 2026
AI 90 Günlük Tahmin
GÜÇLÜ ALIM
7 Gün
30 Gün
90 Gün
Yapay Zeka Güveni: -1% Spearman Korelasyonu
Nisan 02, 2026
NVAX'in tam fiyat hedefini gör
4.000'den fazla hisse için AI tahminlerini açmak üzere ücretsiz hesap oluşturun
Google ile Ücretsiz Kaydol✓ Ücretsiz hesap · ✓ 30 günlük deneme · ✓ İstediğin zaman iptal et
Fiyat Grafiği
Grafik yükleniyor...
Temel İstatistikler
Piyasa Değeri
$1.30B
F/K Oranı
3,0x
P/B Oranı
40,01x
HBK
$2,54
ROE
-238,6%
Net Marj
-32,2%
Gelir
$1B
Cari Oran
1,04x
B/ÖS Oranı
0,70x
Hakkında Novavax Inc
Novavax Inc (NVAX) Life Sciences sektöründe faaliyet göstermektedir, özellikle Biological Products, (No Diagnostic Substances) endüstrisinde. Şirket yaklaşık 375 kişi istihdam etmektedir.
Novavax, Inc., based in Gaithersburg, Maryland, develops vaccines to counter infectious diseases. The company developed the Novavax COVID-19 vaccine, now commercialized by Sanofi. The company also develops vaccines for influenza, respiratory syncytial virus (RSV), avian flu, shingles, Clostridioides difficile, and malaria. Novavax develops proprietary immune-stimulating saponin-based immunologic adjuvants at a wholly owned Swedish subsidiary, Novavax AB. One of these, Matrix-M, is used in the Novavax COVID-19 vaccine.
Biological Products, (No Diagnostic Substances) Benzer Şirketler
| Şirket | Ticker | AI Sinyali | Piyasa Değeri | F/K |
|---|---|---|---|---|
| Acumen Pharmaceuticals, Inc. | ABOS | ██% | $188M | -1,9x |
| Abpro Holdings, Inc. | ABP | ██% | $310K | -x |
| Abpro Holdings, Inc. | ABPO | ██% | $460K | -x |
| Arcellx, Inc. | ACLX | ██% | $6.65B | -74,1x |
| Alpha Cognition Inc. | ACOG | ██% | $134M | -x |
| Adaptimmune Therapeutics Plc | ADAP | ██% | $77M | -13,2x |
| Adma Biologics, Inc. | ADMA | ██% | $2.17B | 14,8x |
| Adaptive Biotechnologies Corp | ADPT | ██% | $2.25B | -4,6x |
| Adverum Biotechnologies, Inc. | ADVM | ██% | $95M | -1,8x |
| Agenus Inc | AGEN | ██% | $120M | 1047,3x |
| Agentix Corp. | AGTX | ██% | $2M | -x |
| Aim Immunotech Inc. | AIM | ██% | $2M | -0,5x |
| Aim Immunotech Inc. | AIMI | ██% | $1M | -x |
| Alector, Inc. | ALEC | ██% | $251M | -1,2x |
| Aligos Therapeutics, Inc. | ALGS | ██% | $49M | -19,2x |
| Allogene Therapeutics, Inc. | ALLO | ██% | $593M | -1,4x |
| Alvotech | ALVO | ██% | $1.13B | -x |
| Amgen Inc | AMGN | ██% | $190.18B | 24,7x |
| Apogee Therapeutics, Inc. | APGE | ██% | $5.77B | -20,5x |
| Aptose Biosciences Inc. | APTOF | ██% | $4M | -x |
| Argenx Se | ARGX | ██% | $46.03B | -x |
| Armata Pharmaceuticals, Inc. | ARMP | ██% | $378M | -1,0x |
| Artiva Biotherapeutics, Inc. | ARTV | ██% | $165M | -x |
| Leonabio, Inc. | ATHA | ██% | $23M | -0,2x |
| Atara Biotherapeutics, Inc. | ATRA | ██% | $42M | 1,3x |
| Atyr Pharma Inc | ATYR | ██% | $84M | -3,6x |
| Aura Biosciences, Inc. | AURA | ██% | $416M | -4,9x |
| Autolus Therapeutics Plc | AUTL | ██% | $374M | -x |
| Anavex Life Sciences … | AVXL | ██% | $279M | -17,3x |
| Bioatla, Inc. | BCAB | ██% | $11M | -1,1x |
| Biocardia, Inc. | BCDA | ██% | $12M | -0,6x |
| Brainstorm Cell Therapeutics … | BCLI | ██% | $10M | -4,9x |
| Biocryst Pharmaceuticals Inc | BCRX | ██% | $2.35B | 8,9x |
| Black Diamond Therapeutics, … | BDTX | ██% | $133M | 6,0x |
| Beam Therapeutics Inc. | BEAM | ██% | $2.46B | -12,6x |
| Biogen Inc. | BIIB | ██% | $26.98B | 20,9x |
| Biontech Se | BNTX | ██% | $22.47B | -x |
| Cabaletta Bio, Inc. | CABA | ██% | $269M | -1,6x |
| Candel Therapeutics, Inc. | CADL | ██% | $365M | -4,6x |
| C4 Therapeutics, Inc. | CCCC | ██% | $262M | -2,6x |
| Cidara Therapeutics, Inc. | CDTX | ██% | $6.49B | -1,0x |
| Creative Medical Technology … | CELZ | ██% | $7M | -3,4x |
| Cero Therapeutics Holdings, … | CERO | ██% | $650K | -x |
| Cullinan Therapeutics, Inc. | CGEM | ██% | $840M | -4,1x |
| Compugen Ltd | CGEN | ██% | $211M | 3,0x |
| Cg Oncology, Inc. | CGON | ██% | $5.39B | -x |
| Cognition Therapeutics Inc | CGTX | ██% | $76M | -0,5x |
| Coherus Oncology, Inc. | CHRS | ██% | $256M | 1,5x |
| Calidi Biotherapeutics, Inc. | CLDI | ██% | $2M | -0,9x |
| Cellectis S.A. | CLLS | ██% | $344M | -x |
| Compass Therapeutics, Inc. | CMPX | ██% | $968M | -4,8x |
| Mosaic Immunoengineering Inc. | CPMV | ██% | $5M | -x |
| Caribou Biosciences, Inc. | CRBU | ██% | $142M | -1,5x |
| Cardiff Oncology, Inc. | CRDF | ██% | $110M | -4,0x |
| Cardiol Therapeutics Inc. | CRDL | ██% | $156M | -x |
| Curis Inc | CRIS | ██% | $22M | -0,3x |
| Crispr Therapeutics Ag | CRSP | ██% | $4.70B | -12,1x |
| Champions Oncology, Inc. | CSBR | ██% | $82M | 32,9x |
| Cel Sci Corp | CVM | ██% | $29M | -0,9x |
| Dbv Technologies S.A. | DBVT | ██% | $1.24B | -3,3x |
| Dbv Technologies S.A. | DBVTF | ██% | $10K | -x |
| Ginkgo Bioworks Holdings, … | DNA | ██% | $395M | -13,9x |
| Denali Therapeutics Inc. | DNLI | ██% | $3.23B | -8,7x |
| Precision Biosciences Inc | DTIL | ██% | $137M | -2,2x |
| Dyadic International Inc | DYAI | ██% | $31M | -7,3x |
| Editas Medicine, Inc. | EDIT | ██% | $255M | -0,8x |
| Eloxx Pharmaceuticals, Inc. | ELOX | ██% | $710K | -x |
| Elutia Inc. | ELUT | ██% | $45M | 0,9x |
| Engene Holdings Inc. | ENGN | ██% | $453M | 3,7x |
| Entera Bio Ltd. | ENTX | ██% | $53M | 8,5x |
| Viskase Holdings, Inc. | ENZN | ██% | $4M | -x |
| Estrella Immunopharma, Inc. | ESLA | ██% | $45M | -3,1x |
| Evaxion A/S | EVAX | ██% | $33M | -x |
| Exelixis, Inc. | EXEL | ██% | $11.56B | 14,8x |
| Exozymes Inc. | EXOZ | ██% | $71M | -x |
| Fate Therapeutics Inc | FATE | ██% | $143M | -1,3x |
| 4d Molecular Therapeutics, … | FDMT | ██% | $504M | -3,0x |
| Fennec Pharmaceuticals Inc. | FENC | ██% | $219M | 1758,3x |
| Finch Therapeutics Group, … | FNCH | ██% | $15M | 0,5x |
| Futuretech Ii Acquisition … | FTII | ██% | $52M | -x |
| Futuretech Ii Acquisition … | FTIIU | ██% | $14M | -x |
| Gilead Sciences, Inc. | GILD | ██% | $174.11B | 20,5x |
| Monte Rosa Therapeutics, … | GLUE | ██% | $1.37B | 59,5x |
| Genenta Science S.P.A. | GNTA | ██% | $16M | -x |
| Green Planet Bio … | GPLB | ██% | $340K | -x |
| Greenland Mines Ltd | GRML | ██% | $44M | -x |
| Halozyme Therapeutics, Inc. | HALO | ██% | $7.54B | 23,8x |
| Humacyte, Inc. | HUMA | ██% | $131M | -3,3x |
| Immunitybio, Inc. | IBRX | ██% | $7.22B | -3,6x |
| Inhibikase Therapeutics, Inc. | IKT | ██% | $238M | -1,0x |
| Imagenebio, Inc. | IMA | ██% | $56M | -x |
| Immunocore Holdings Plc | IMCR | ██% | $1.54B | -x |
| Immatics N.V. | IMTX | ██% | $1.34B | -x |
| Immunovant, Inc. | IMVT | ██% | $5.06B | -14,5x |
| In8bio, Inc. | INAB | ██% | $14M | -x |
| Inhibrx Biosciences, Inc. | INBX | ██% | $873M | -6,8x |
| Mink Therapeutics, Inc. | INKT | ██% | $45M | -1,5x |
| Inmune Bio, Inc. | INMB | ██% | $33M | -2,5x |
| Intensity Therapeutics, Inc. | INTS | ██% | $14M | -2,2x |
| Iovance Biotherapeutics, Inc. | IOVA | ██% | $1.41B | -4,5x |
| Century Therapeutics, Inc. | IPSC | ██% | $394M | -0,7x |
| Invivyd, Inc. | IVVD | ██% | $360M | -0,4x |
| Jasper Therapeutics, Inc. | JSPR | ██% | $22M | -3,2x |
| Kalaris Therapeutics, Inc. | KLRS | ██% | $136M | -x |
| Klotho Neurosciences, Inc. | KLTO | ██% | $56M | -x |
| Kodiak Sciences Inc. | KOD | ██% | $2.64B | -2,5x |
| Krystal Biotech, Inc. | KRYS | ██% | $7.56B | 36,9x |
| Kymera Therapeutics, Inc. | KYMR | ██% | $6.91B | -17,8x |
| Kyverna Therapeutics, Inc. | KYTX | ██% | $530M | -x |
| Ladrx Corp | LADX | ██% | $20K | -x |
| Lineage Cell Therapeutics, … | LCTX | ██% | $387M | -4,7x |
| Lenz Therapeutics, Inc. | LENZ | ██% | $293M | -6,7x |
| Liminatus Pharma, Inc. | LIMN | ██% | $7M | -x |
| Leonabio, Inc. | LONA | ██% | $106M | -x |
| Lexeo Therapeutics, Inc. | LXEO | ██% | $414M | -0,4x |
| Maze Therapeutics, Inc. | MAZE | ██% | $1.43B | -x |
| Mesoblast Ltd | MESO | ██% | $2.07B | -x |
| Meiragtx Holdings Plc | MGTX | ██% | $737M | -3,4x |
| Metagenomi Therapeutics, Inc. | MGX | ██% | $50M | -x |
| Molecular Partners Ag | MOLN | ██% | $162M | -x |
| Moderna, Inc. | MRNA | ██% | $19.71B | -3,2x |
| Neurocrine Biosciences Inc | NBIX | ██% | $13.27B | 27,7x |
| Nkgen Biotech, Inc. | NKGN | ██% | $2M | -0,1x |
| Neumora Therapeutics, Inc. | NMRA | ██% | $348M | -3,9x |
| Novavax Inc | NVAX | ██% | $1.30B | 3,0x |
| Ocugen, Inc. | OCGN | ██% | $559M | -4,3x |
| Outlook Therapeutics, Inc. | OTLK | ██% | $22M | -0,2x |
| Palisade Bio, Inc. | PALI | ██% | $312M | -0,2x |
| Passage Bio, Inc. | PASG | ██% | $25M | -0,6x |
| Vaxcyte, Inc. | PCVX | ██% | $7.67B | -20,4x |
| Biomx Inc. | PHGE | ██% | $22M | 1,5x |
| Pluri Inc. | PLUR | ██% | $33M | -1,4x |
| Protalix Biotherapeutics, Inc. | PLX | ██% | $176M | 41,2x |
| Pharmacyte Biotech, Inc. | PMCB | ██% | $7M | 0,3x |
| Prime Medicine, Inc. | PRME | ██% | $599M | -1,5x |
| Prokidney Corp. | PROK | ██% | $527M | -x |
| Pelthos Therapeutics Inc. | PTHS | ██% | $66M | -x |
| Qiagen N.V. | QGEN | ██% | $8.86B | -x |
| Quince Therapeutics, Inc. | QNCX | ██% | $5M | -1,7x |
| Qrons Inc. | QRON | ██% | $150K | -x |
| Replimune Group, Inc. | REPL | ██% | $606M | -3,8x |
| Repligen Corp | RGEN | ██% | $6.66B | 136,3x |
| Regenxbio Inc. | RGNX | ██% | $439M | -1,8x |
| Relay Therapeutics, Inc. | RLAY | ██% | $1.87B | -2,0x |
| Revolution Medicines, Inc. | RVMD | ██% | $19.43B | -11,1x |
| Recursion Pharmaceuticals, Inc. | RXRX | ██% | $1.62B | -4,7x |
| Sab Biotherapeutics, Inc. | SABS | ██% | $271M | 20,4x |
| Sana Biotechnology, Inc. | SANA | ██% | $846M | -2,1x |
| Scilex Holding Co | SCLX | ██% | $49M | -0,4x |
| Scinai Immunotherapeutics Ltd. | SCNI | ██% | $2M | -287,8x |
| Sangamo Therapeutics, Inc | SGMO | ██% | $91M | -1,6x |
| Solid Biosciences Inc. | SLDB | ██% | $726M | -0,9x |
| Silexion Therapeutics Corp | SLXN | ██% | $4M | -x |
| Senti Biosciences, Inc. | SNTI | ██% | $26M | -1,1x |
| Scholar Rock Holding … | SRRK | ██% | $5.35B | -18,5x |
| Surrozen, Inc./De | SRZN | ██% | $335M | -0,5x |
| Sutro Biopharma, Inc. | STRO | ██% | $392M | -1,0x |
| Protara Therapeutics, Inc. | TARA | ██% | $270M | -2,1x |
| Tarsus Pharmaceuticals, Inc. | TARS | ██% | $2.99B | -12,4x |
| Tc Biopharm (Holdings) … | TCBPY | ██% | $10K | -x |
| Tscan Therapeutics, Inc. | TCRX | ██% | $57M | -4,6x |
| Bio-Techne Corp | TECH | ██% | $8.34B | 102,8x |
| Tectonic Therapeutic, Inc. | TECX | ██% | $575M | -8,9x |
| Instil Bio, Inc. | TIL | ██% | $54M | -1,1x |
| Tenaya Therapeutics, Inc. | TNYA | ██% | $151M | -2,5x |
| Tourmaline Bio, Inc. | TRML | ██% | $1.23B | -3,5x |
| Taysha Gene Therapies, … | TSHA | ██% | $1.25B | -3,0x |
| Titan Pharmaceuticals Inc | TTNP | ██% | $6M | -0,5x |
| Tevogen Bio Holdings … | TVGN | ██% | $18M | -x |
| Twist Bioscience Corp | TWST | ██% | $3.08B | -12,6x |
| Voyager Acquisition Corp./Cayman … | VACH | ██% | $374M | 41,6x |
| Voyager Acquisition Corp./Cayman … | VACHU | ██% | $68M | 6,7x |
| Valneva Se | VALN | ██% | $530M | -x |
| Vericel Corp | VCEL | ██% | $1.59B | 96,5x |
| Vir Biotechnology, Inc. | VIR | ██% | $1.47B | -2,0x |
| Vivosim Labs, Inc. | VIVS | ██% | $4M | -x |
| Vor Biopharma Inc. | VOR | ██% | $882M | -0,6x |
| Vaxart, Inc. | VXRT | ██% | $151M | 9,3x |
| Voyager Therapeutics, Inc. | VYGR | ██% | $234M | 570,6x |
| Windtree Therapeutics Inc … | WINT | ██% | $340K | -0,4x |
| X4 Pharmaceuticals, Inc | XFOR | ██% | $402M | 6,4x |
| Zeo Scientifix, Inc. | ZEOX | ██% | $17M | -x |
| Zivo Bioscience, Inc. | ZIVO | ██% | $25M | -31,3x |
| Zura Bio Ltd | ZURA | ██% | $559M | -x |
SSS
-
Novavax Inc satın alınacak iyi bir hisse mi?
AI'mız Novavax Inc'i günlük olarak analiz eder. En son öneri için yukarıdaki sinyali kontrol edin. Yatırım yapmadan önce her zaman kendi araştırmanızı yapın.
-
Novavax Inc tahminleri ne kadar doğru?
AI'mız bu hisse için -1% Spearman korelasyonu elde eder, günlük analiz edilen 4.000'den fazla hissede ortalama %67+ doğruluk oranıyla.
-
Tahminler ne sıklıkla güncellenir?
Novavax Inc tahminleri en son piyasa verileri ve AI modelleri kullanılarak günlük olarak güncellenir.
Daha akıllı yatırım yapmaya hazır mısınız?
AI destekli hisse tahminlerini kullanan binlerce yatırımcıya katılın
Ücretsiz Kaydolun✓ Ücretsiz hesap · ✓ 4.000+ hisse · ✓ Günlük güncellemeler
Novavax Inc için daha derin bir analiz mi arıyorsunuz?
Intratio'da tam kurumsal düzey analizi görüntüle →AI tahminleri tarihsel kalıplara dayanır ve yatırım kararlarının tek dayanağı olmamalıdır. Geçmiş performans gelecekteki sonuçları garanti etmez. Her zaman kendi araştırmanızı yapın.